Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?
Lung cancer is one of the most lethal malignancies worldwide, mainly due to its late diagnoses. The detection of molecular markers on samples provided from routine bronchoscopy including several liquid-based cytology tests (e.g., bronchoaspirate, bronchoalveolar lavage) and/or on easily obtained spe...
Main Authors: | Fiorella Calabrese, Francesca Lunardi, Federica Pezzuto, Francesco Fortarezza, Stefania Edith Vuljan, Charles Marquette, Paul Hofman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/3/414 |
Similar Items
-
Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study
by: Eloisa Jantus-Lewintre, et al.
Published: (2021-07-01) -
Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
by: Milena Matuszczak, et al.
Published: (2021-07-01) -
Required Evidence for Clinical Applications of Liquid Biopsy Using Especially CTCs in Lung Cancer
by: Menno Tamminga, et al.
Published: (2020-05-01) -
Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages
by: Florian Janke, et al.
Published: (2020-04-01) -
miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma
by: Beatriz C. Lopes, et al.
Published: (2021-01-01)